| Date | Time | Source | Announcement |
|---|---|---|---|
| 24 Jan 2024 | 05:00 PM | Transaction in Own Shares | |
| 24 Jan 2024 | 12:47 PM | Net Asset Value(s) | |
| 23 Jan 2024 | 05:18 PM | Transaction in Own Shares | |
| 23 Jan 2024 | 11:32 AM | Net Asset Value(s) | |
| 23 Jan 2024 | 07:00 AM | Baillie Gifford US Growth Trust Interim Results | |
| 22 Jan 2024 | 12:00 PM | Net Asset Value(s) | |
| 19 Jan 2024 | 11:51 AM | Net Asset Value(s) | |
| 18 Jan 2024 | 11:32 AM | Net Asset Value(s) | |
| 17 Jan 2024 | 11:38 AM | Net Asset Value(s) | |
| 16 Jan 2024 | 11:25 AM | Net Asset Value(s) | |
| 15 Jan 2024 | 11:19 AM | Net Asset Value(s) | |
| 12 Jan 2024 | 12:53 PM | Net Asset Value(s) | |
| 11 Jan 2024 | 06:00 PM | Dechra Pharmaceuticals | |
| 11 Jan 2024 | 11:00 AM | Net Asset Value(s) | |
| 10 Jan 2024 | 02:47 PM | Net Asset Value(s) | |
| 09 Jan 2024 | 11:28 AM | Net Asset Value(s) | |
| 08 Jan 2024 | 11:07 AM | Net Asset Value(s) | |
| 05 Jan 2024 | 11:20 AM | Net Asset Value(s) | |
| 04 Jan 2024 | 11:59 AM | Net Asset Value(s) | |
| 03 Jan 2024 | 11:28 AM | Net Asset Value(s) | |
| 02 Jan 2024 | 05:07 PM | Net Asset Value(s) | |
| 02 Jan 2024 | 04:17 PM | Net Asset Value(s) | |
| 02 Jan 2024 | 11:40 AM | Total Voting Rights | |
| 29 Dec 2023 | 11:05 AM | Net Asset Value(s) | |
| 28 Dec 2023 | 10:52 AM | Net Asset Value(s) | |
| 27 Dec 2023 | 01:04 PM | Net Asset Value(s) | |
| 27 Dec 2023 | 12:04 PM | Net Asset Value(s) | |
| 27 Dec 2023 | 11:08 AM | Net Asset Value(s) | |
| 27 Dec 2023 | 11:08 AM | Net Asset Value(s) | |
| 22 Dec 2023 | 10:55 AM | Net Asset Value(s) | |
| 21 Dec 2023 | 11:17 AM | Net Asset Value(s) | |
| 20 Dec 2023 | 12:22 PM | Net Asset Value(s) | |
| 19 Dec 2023 | 12:07 PM | Net Asset Value(s) | |
| 18 Dec 2023 | 12:09 PM | Net Asset Value(s) | |
| 15 Dec 2023 | 11:55 AM | Net Asset Value(s) | |
| 14 Dec 2023 | 11:42 AM | Net Asset Value(s) | |
| 13 Dec 2023 | 05:27 PM | Transaction in Own Shares | |
| 13 Dec 2023 | 12:13 PM | Net Asset Value(s) | |
| 12 Dec 2023 | 11:43 AM | Net Asset Value(s) | |
| 11 Dec 2023 | 12:00 PM | Net Asset Value(s) | |
| 08 Dec 2023 | 11:55 AM | Net Asset Value(s) | |
| 07 Dec 2023 | 12:01 PM | Net Asset Value(s) | |
| 06 Dec 2023 | 11:16 AM | Net Asset Value(s) | |
| 05 Dec 2023 | 11:40 AM | Net Asset Value(s) | |
| 04 Dec 2023 | 11:24 AM | Net Asset Value(s) | |
| 01 Dec 2023 | 03:46 PM | Total Voting Rights | |
| 01 Dec 2023 | 11:53 AM | Closed Period Confirmation | |
| 01 Dec 2023 | 11:30 AM | Net Asset Value(s) | |
| 30 Nov 2023 | 12:01 PM | Net Asset Value(s) | |
| 29 Nov 2023 | 04:39 PM | Transaction in Own Shares |
Baillie Gifford US Growth Trust is a large British investment trust. Established in 2018, it is dedicated to investments in United States-based companies.It is listed on the London Stock Exchange under the ticker USA and is a constituent of the FTSE 250 Index. It is managed by Edinburgh-based investment manager Baillie Gifford. The managers are authorised to have up to 50% of the portfolio invested in unlisted companies, a higher proportion than some other investment trusts.
Baillie Gifford US Growth Trust share price launched at 101p in 2018.